Home > Healthcare > Medical Devices > Therapeutic Devices > Ophthalmic Eye Dropper Market

Ophthalmic Eye Dropper Market Trends

Report ID: GMI8332
Published Date: Feb 2024
Report Format: PDF

Download Free Sample

Ophthalmic Eye Dropper Market Trends

Technological advancements in ophthalmic drug delivery systems play a significant role in the ophthalmic eye dropper industry. As, these advancements aim to improve drug delivery accuracy, increase patient comfort, enhance medication efficacy, and promote better treatment adherence.

The introduction of preservative-free eye dropper has revolutionized the market with improved stability, controlled release, and targeted delivery to specific ocular tissues.
For instance, Alcon's launch of Systane complete preservative-free lubricant eye drops in January 2022, demonstrated the ongoing efforts to improve the range of products for dry eyes. These eye drops come in an easy-to-use bottle that can be used for multiple doses, making it simpler for patients who need preservative-free options.
Furthermore, eye droppers are equipped with sensors to detect when a drop is released, ensuring proper dosing, and reducing over-medication. This feedback mechanism provide alerts or indicators when the correct dose is administered.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The market size of ophthalmic eye dropper reached USD 13.3 billion in 2023 and is set to witness 6.3% CAGR between 2024 and 2032, led by the rising prevalence of various eye disorders globally.

Preserved multi-dose ophthalmic eye dropper segment generated USD 6.4 billion in revenue in 2023, owing to growing preference as they have a longer shelf life compared to preservative-free single-dose units.

North America market size was USD 5.4 billion in 2023, due to the presence of a large aging population susceptible to age-related eye conditions.

Some of the leading firms engaged in the market are AbbVie Inc., Alcon plc, AptarGroup, Inc., Bausch & Lomb Incorporated, Novartis AG, PanOptica, Inc., Pfizer Inc, Sager Pharma Kft, Silgan Dispensing Systems LLC, and Similasan Corp.